BACKGROUND: Enterococcus faecium has rapidly emerged as a nosocomial pathogen worldwide, and the majority of these isolates belong to clonal complex-17 (CC17). In Europe, CC17 isolates are usually ampicillin-resistant, but most are still vancomycin-sensitive. We aimed to study ampicillin-resistant E. faecium (ARE) epidemiology in our hospital. METHODS: In a 3 month study, 210 of 358 admissions (59%) to haematology and gastroenterology/nephrology were screened for rectal ARE colonization on admission (<48 h) and 148 of 210 (70%) also at discharge (<72 h). In a second (3 month) study, environmental swabs from eight predetermined sites were obtained from ARE-colonized haematology patients once weekly. All ARE isolates were genotyped by multiple-locus variable-number tandem repeat analysis (MLVA). RESULTS: ARE admission prevalence was 10% and 16% and acquisition rates were 39% and 15% in haematology and gastroenterology/nephrology, respectively. Carriage on admission was associated with previous admission <1 year (OR 5.0, 95% CI 1.8-14.0) and acquisition with beta-lactam (OR 2.7, 95% CI 1.1-6.7) and quinolone use (OR 3.1, 95% CI 1.1-8.2). Five of the 57 (9%) colonized patients developed invasive ARE infections. Genotyping revealed 12 genotypes (all CC17) with two MLVA types responsible for 94% of acquisitions. In 18 of the 19 colonized patients, the environment was contaminated with ARE. Sites most often contaminated were the toilet seat (43%), over-bed table (34%) and television remote control (28%). CONCLUSIONS: CC17 ARE epidemiology is characterized by high admission (10% to 16%), acquisition (15% to 39%) and environmental contamination (22%) rates, resulting from cross-transmission, readmission and antibiotic pressure. A multifaceted infection control approach will be needed to curtail further spread.
BACKGROUND:Enterococcus faecium has rapidly emerged as a nosocomial pathogen worldwide, and the majority of these isolates belong to clonal complex-17 (CC17). In Europe, CC17 isolates are usually ampicillin-resistant, but most are still vancomycin-sensitive. We aimed to study ampicillin-resistant E. faecium (ARE) epidemiology in our hospital. METHODS: In a 3 month study, 210 of 358 admissions (59%) to haematology and gastroenterology/nephrology were screened for rectal ARE colonization on admission (<48 h) and 148 of 210 (70%) also at discharge (<72 h). In a second (3 month) study, environmental swabs from eight predetermined sites were obtained from ARE-colonized haematology patients once weekly. All ARE isolates were genotyped by multiple-locus variable-number tandem repeat analysis (MLVA). RESULTS:ARE admission prevalence was 10% and 16% and acquisition rates were 39% and 15% in haematology and gastroenterology/nephrology, respectively. Carriage on admission was associated with previous admission <1 year (OR 5.0, 95% CI 1.8-14.0) and acquisition with beta-lactam (OR 2.7, 95% CI 1.1-6.7) and quinolone use (OR 3.1, 95% CI 1.1-8.2). Five of the 57 (9%) colonized patients developed invasive ARE infections. Genotyping revealed 12 genotypes (all CC17) with two MLVA types responsible for 94% of acquisitions. In 18 of the 19 colonized patients, the environment was contaminated with ARE. Sites most often contaminated were the toilet seat (43%), over-bed table (34%) and television remote control (28%). CONCLUSIONS: CC17 ARE epidemiology is characterized by high admission (10% to 16%), acquisition (15% to 39%) and environmental contamination (22%) rates, resulting from cross-transmission, readmission and antibiotic pressure. A multifaceted infection control approach will be needed to curtail further spread.
Authors: Mark de Been; Mette Pinholt; Janetta Top; Stefan Bletz; Alexander Mellmann; Willem van Schaik; Ellen Brouwer; Malbert Rogers; Yvette Kraat; Marc Bonten; Jukka Corander; Henrik Westh; Dag Harmsen; Rob J L Willems Journal: J Clin Microbiol Date: 2015-12 Impact factor: 5.948
Authors: Marieke J A de Regt; Rob J L Willems; Ronald J Hené; Peter D Siersema; Harald J J Verhaar; Titia E M Hopmans; Marc J M Bonten Journal: Antimicrob Agents Chemother Date: 2010-04-19 Impact factor: 5.191
Authors: P Ruiz-Garbajosa; M de Regt; M Bonten; F Baquero; T M Coque; R Cantón; H J M Harmsen; R J L Willems Journal: Eur J Clin Microbiol Infect Dis Date: 2011-07-26 Impact factor: 3.267
Authors: J H T Wagenvoort; E I G B De Brauwer; R J R Penders; C J van der Linden; R J Willems; J Top; M J Bonten Journal: Eur J Clin Microbiol Infect Dis Date: 2015-07-21 Impact factor: 3.267
Authors: Marieke J A de Regt; Willem van Schaik; Miranda van Luit-Asbroek; Huberta A T Dekker; Engeline van Duijkeren; Catherina J M Koning; Marc J M Bonten; Rob J L Willems Journal: PLoS One Date: 2012-02-17 Impact factor: 3.240
Authors: Maja Weisser; Evelien A Oostdijk; Rob J L Willems; Marc J M Bonten; Reno Frei; Luigia Elzi; Jörg Halter; Andreas F Widmer; Janetta Top Journal: BMC Infect Dis Date: 2012-03-22 Impact factor: 3.090
Authors: Esther Heikens; Masja Leendertse; Lucas M Wijnands; Miranda van Luit-Asbroek; Marc J M Bonten; Tom van der Poll; Rob J L Willems Journal: BMC Microbiol Date: 2009-01-29 Impact factor: 3.605
Authors: Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Joris J T H Roelofs; Janetta Top; Marc J M Bonten; Tom van der Poll Journal: PLoS One Date: 2009-08-27 Impact factor: 3.240